Xing et al. 23F Abrupt Onset of Hypertension

Xing et al. 23F Abrupt Onset of Hypertension

by | Apr 27, 2021

MultiHance® 9 Image Library 9 Xing et al. 23F Abrupt Onset of Hypertension MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL—High Diagnostic Performance for Stenosis Detection 1 Xing et al.23-year-old woman with abrupt onset of hypertension These are...
Gerretsen et al. 74M Moderate Claudication

Gerretsen et al. 74M Moderate Claudication

by | Apr 27, 2021

MultiHance® 9 Image Library 9 Gerretsen et al. 74M Moderate Claudication MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL—High Diagnostic Performance for Stenosis Detection1 Gerretsen et al.74-year-old man with moderate claudication in the calf (Fontaine IIb)...
Seidl et al. 70M Metastatic Lung Carcinoma

Seidl et al. 70M Metastatic Lung Carcinoma

by | Apr 27, 2021

MultiHance® 9 Image Library 9 Seidl et al. 70M Metastatic Lung Carcinoma MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL vs. Gadavist® (gadobutrol)1 The MERIT StudySeidl et al.70-year-old man with metastatic lung carcinoma These are representative images...
Seidl et al. 58F Metastatic Melanoma

Seidl et al. 58F Metastatic Melanoma

by | Apr 27, 2021

MultiHance® 9 Image Library 9 Seidl et al. 58F Metastatic Melanoma MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL vs. Gadavist® (gadobutrol)1 The MERIT StudySeidl et al.58-year-old woman with metastatic melanoma These are representative images from...
Rowley et al. 55F Glioblastoma with Recurrent Disease

Rowley et al. 55F Glioblastoma with Recurrent Disease

by | Apr 27, 2021

MultiHance® 9 Image Library 9 Rowley et al. 55F Glioblastoma with Recurrent Disease MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL Improves Visualization and Enhancement of Lesions vs. Omniscan™ (gadodiamide)1 The ENHANCE Study Rowley et al. 55-year-old...